# Artivion

Artivion is an Asset Manager based in Kennesaw, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Kennesaw, United States
- **Region:** North America
- **Address:** 1655 Roberts Blvd., NW Kennesaw, GA 30144, United States
- **Founded:** 1984
- **Assets under management:** Undisclosed
- **Website:** artivion.com
- **LinkedIn:** https://www.linkedin.com/company/artivion

## Regulatory record

- **Reports private funds:** No

## About

Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with diseases of the aorta and to deliver breakthrough technologies of unsurpassed quality that have far-reaching impact.

## Sectors

- MedTech
- Healthcare Services

## Offices

- Hechingen, Germany
- Bangkok, Thailand
- Singapore

## People

- J. Patrick Mackin — Chairman, President, and Chief Executive Officer
- Lance Berry — Executive Vice President, Chief Operating Officer, and Chief Financial Officer
- John E. Davis — Chief Commercial Officer
- Jean F. Holloway — Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
- Simona Zannetti — Senior Vice President of Clinical Research and Chief Medical Officer
- Jason Asper — Senior Vice President and Chief Strategy and Digital Officer

## Questions

### Who runs investment decisions at Artivion?

J. Patrick Mackin serves as Chairman, President, and CEO, leading corporate strategy and capital allocation. Lance Berry, appointed EVP, COO, and CFO in December 2023, oversees financial operations. Major M&A and R&D decisions are made by the executive team and board.

### Does Artivion participate in fund commitments or only direct operations?

As a medical device company, Artivion does not make external fund commitments. Its capital is deployed into internal R&D, manufacturing, clinical trials, and strategic acquisitions.

### What investment stages does Artivion typically target?

Artivion targets later-stage commercial medical devices, often acquiring or developing products that already have regulatory clearance or are in pivotal trials. Examples include the AMDS Hybrid Prosthesis and On-X heart valves.

### Which sectors does Artivion explicitly avoid?

Artivion focuses exclusively on aortic and cardiac surgery technologies. It does not pursue non-surgical therapies, pharmaceutical drugs, or general healthcare services outside its core aortic device domain.

## Related profiles

- [Legacy-Xspire Holdings](https://altss.com/profile/legacy-xspire-holdings)
- [JMD Properties](https://altss.com/profile/jmd-properties)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/artivion

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology